An Evaluation of the Efficacy of High-dose Hepatitis B Vaccine in Patients Using Biological Agents


AYDIN M., AKSOY F., Yildirim Z., Koksal I.

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, cilt.26, sa.2, ss.88-93, 2020 (Hakemli Dergi) identifier

Özet

Objectives: Hepatitis B virus (HBV) vaccination is efficient in the normal population, whereas lower humoral response rates in immunosuppressed patients. Biological agents used in the treatment of several diseases in recent years are a significant cause of immunosuppression in patients. In this study we aimed to evaluate the efficacy of double-dose HBV vaccination at months 0, 1, 2, and 6 in patients using biological agents.